Search
Advanced Search
Metrics info
Average Rating (0 User Ratings)
    • Currently 0/5 Stars.
    See all categories
      • Currently 0/5 Stars.
      • Currently 0/5 Stars.
      • Currently 0/5 Stars.
    Rate This Article
More
Share this Article info
  • StumbleUpon Facebook Connotea CiteULike Bibliography

Open Access

Research Article

Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

0 responses
 Linked Perspective: "ADAPT: The Wrong Way to Stop a Clinical Trial" Posted by ClinicalTrialsHub on 26 Oct 2007 at 09:43 GMT
Most recent response on 26 Oct 2007 at 09:43 GMT
0 responses
 Invalid Conclusions Drawn from ADAPT Study Posted by ClinicalTrialsHub on 26 Oct 2007 at 09:33 GMT
Most recent response on 26 Oct 2007 at 09:33 GMT
0 responses
 Aspirin confounding may increase differences in cardiovascular risk between coxibs and NSAIDS in clinical trials Posted by ClinicalTrialsHub on 26 Oct 2007 at 08:46 GMT
Most recent response on 26 Oct 2007 at 08:46 GMT
0 responses
 Naproxen might affect cardioprotective effect of aspirin in ADAPT Posted by ClinicalTrialsHub on 25 Oct 2007 at 16:03 GMT
Most recent response on 25 Oct 2007 at 16:03 GMT
Rate This Article
Please follow our guidelines for rating and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
  1. Remarks that could be interpreted as allegations of misconduct
  2. Unsupported assertions or statements
  3. Inflammatory or insulting language
Compose Your Annotation
 
Declare any competing interests.

Ratings can include the following markup tags:

Emphasis: ''italic''  '''bold'''  '''''bold italic'''''

Other: ^^superscript^^  ~~subscript~~

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution License.